These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

800 related articles for article (PubMed ID: 15985104)

  • 21. Use of almotriptan in triptan-experienced and triptan-naïve patients.
    Pascual J; Diener HC
    Curr Med Res Opin; 2007 Oct; 23(10):2433-40. PubMed ID: 17723158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of migraine headache recurrence: a pooled analysis from the eletriptan database.
    Dodick DW; Lipton RB; Goadsby PJ; Tfelt-Hansen P; Ferrari MD; Diener HC; Almas M; Albert KS; Parsons B
    Headache; 2008 Feb; 48(2):184-93. PubMed ID: 18234045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies.
    Visser WH; Winner P; Strohmaier K; Klipfel M; Peng Y; McCarroll K; Cady R; Lewis D; Nett R;
    Headache; 2004 Oct; 44(9):891-9. PubMed ID: 15447698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine.
    Chen LC; Ashcroft DM
    Headache; 2008 Feb; 48(2):236-47. PubMed ID: 18179569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Consistent efficacy, tolerability, and high levels of satisfaction with almotriptan 12.5 mg when used to treat multiple migraine attacks in routine clinical practice.
    Diener HC
    Headache; 2005 Jun; 45(6):624-31. PubMed ID: 15953293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early vs. non-early intervention in acute migraine-'Act when Mild (AwM)'. A double-blind, placebo-controlled trial of almotriptan.
    Goadsby PJ; Zanchin G; Geraud G; de Klippel N; Diaz-Insa S; Gobel H; Cunha L; Ivanoff N; Falques M; Fortea J
    Cephalalgia; 2008 Apr; 28(4):383-91. PubMed ID: 18294251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eletriptan for the acute treatment of migraine in adolescents: results of a double-blind, placebo-controlled trial.
    Winner P; Linder SL; Lipton RB; Almas M; Parsons B; Pitman V
    Headache; 2007 Apr; 47(4):511-8. PubMed ID: 17445100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy, speed of action and tolerability of almotriptan in the acute treatment of migraine: pooled individual patient data from four randomized, double-blind, placebo-controlled clinical trials.
    Dahlöf CG; Pascual J; Dodick DW; Dowson AJ
    Cephalalgia; 2006 Apr; 26(4):400-8. PubMed ID: 16556240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and tolerability of almotriptan versus zolmitriptan for the acute treatment of menstrual migraine.
    Allais G; Acuto G; Cabarrocas X; Esbri R; Benedetto C; Bussone G
    Neurol Sci; 2006 May; 27 Suppl 2():S193-7. PubMed ID: 16688629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Almotriptan and zolmitriptan in the acute treatment of migraine.
    Goadsby PJ; Massiou H; Pascual J; Diener HC; Dahlöf CG; Mateos V; Dowson AJ; Raets I; Cunha L; Färkkilä M; Manzoni GC
    Acta Neurol Scand; 2007 Jan; 115(1):34-40. PubMed ID: 17156263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zolmitriptan 5 mg nasal spray: efficacy and onset of action in the acute treatment of migraine--results from phase 1 of the REALIZE Study.
    Gawel M; Aschoff J; May A; Charlesworth BR;
    Headache; 2005 Jan; 45(1):7-16. PubMed ID: 15663607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A double-blind placebo-controlled study assessing the efficacy and tolerability of 50 mg sumatriptan tablets in the acute treatment of migraine. Sumatriptan Tablets S2CM07 Study Group.
    Savani N; Brautaset NJ; Reunanen M; Szirmai I; Ashford EA; Hassani H; Saiers J
    Int J Clin Pract Suppl; 1999 Aug; 105():7-15. PubMed ID: 10692717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of sumatriptan 50 mg in patients not responding to standard care, in the treatment of mild to moderate migraine. The Sumatriptan 50 mg Italian Study Group.
    Pini LA; Fabbri L; Cavazzuti L
    Int J Clin Pharmacol Res; 1999; 19(2):57-64. PubMed ID: 10669900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral almotriptan vs. oral sumatriptan in the abortive treatment of migraine: a double-blind, randomized, parallel-group, optimum-dose comparison.
    Spierings EL; Gomez-Mancilla B; Grosz DE; Rowland CR; Whaley FS; Jirgens KJ
    Arch Neurol; 2001 Jun; 58(6):944-50. PubMed ID: 11405809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The long-term tolerability and efficacy of oral zolmitriptan (Zomig, 311C90) in the acute treatment of migraine. An international study. The International 311C90 Long-term Study Group.
    Headache; 1998 Mar; 38(3):173-83. PubMed ID: 9563207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multimechanistic (sumatriptan-naproxen) early intervention for the acute treatment of migraine.
    Silberstein SD; Mannix LK; Goldstein J; Couch JR; Byrd SC; Ames MH; McDonald SA; Lener SE; Toso C
    Neurology; 2008 Jul; 71(2):114-21. PubMed ID: 18606965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allodynia-associated symptoms, pain intensity and time to treatment: predicting treatment response in acute migraine intervention.
    Cady RK; Freitag FG; Mathew NT; Elkind AH; Mao L; Fisher AC; Biondi DM; Finlayson G; Greenberg SJ; Hulihan JF
    Headache; 2009 Mar; 49(3):350-63. PubMed ID: 19220503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacology and efficacy of eletriptan for the treatment of migraine attacks.
    Diener HC; McHarg A
    Int J Clin Pract; 2000 Dec; 54(10):670-4. PubMed ID: 11221281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infrequent or non-response to oral sumatriptan does not predict response to other triptans--review of four trials.
    Dahlöf CG
    Cephalalgia; 2006 Feb; 26(2):98-106. PubMed ID: 16426262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sumatriptan suppositories for the acute treatment of migraine. S2B351 Study Group.
    Tepper SJ; Cochran A; Hobbs S; Woessner M
    Int J Clin Pract; 1998; 52(1):31-5. PubMed ID: 9536565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.